How useful are circulating tumor cells for early diagnosis?
Pediatric News ,
Treatment options for patients with cancer that is detected at a late stage are severely limited, which usually leads to an…
Treatment options for patients with cancer that is detected at a late stage are severely limited, which usually leads to an…
Treatment options for patients with cancer that is detected at a late stage are severely limited, which usually leads to an…
Liquid biopsies are becoming an increasingly imperative tool in the early detection, prognosis, and monitoring of treatment…
Identifying the molecular features of metastatic breast cancer (MBC) offers a real-time window into a patient's treatment…
Identifying the molecular features of metastatic breast cancer (MBC) offers a real-time window into a patient's treatment…
Joseph A. Sparano, MD Blood-based biomarkers great potential for use in the management of breast and other cancers.
The use of circulating tumor cell (CTC) and cell-free DNA assessments offer promise as prognostic biomarkers and in tailoring…
Advertisement Victor G. Vogel, MD, MHS The reality is that we can no longer afford the luxury of using either pathologic…
In a move away from the previous belief that cell populations are homogeneous and display identical molecular characteristics…
As part of our coverage of the American Association for Cancer Research (AACR) Annual Meeting, held April 1–5 in Washington, DC…
All truths are easy to understand once they are discovered; the point is to discover them.” —Galileo Galilei